Johnson Investment Counsel Inc Atea Pharmaceuticals, Inc. Transaction History
Johnson Investment Counsel Inc
- $10.9 Billion
- Q2 2025
A detailed history of Johnson Investment Counsel Inc transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Johnson Investment Counsel Inc holds 15,340 shares of AVIR stock, worth $50,161. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,340Holding current value
$50,161% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AVIR
# of Institutions
111Shares Held
48.9MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY9.12MShares$29.8 Million0.0% of portfolio
-
Bml Capital Management, LLC Zionsville, IN7.61MShares$24.9 Million20.73% of portfolio
-
Tang Capital Management LLC San Diego, CA4.89MShares$16 Million1.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.89MShares$16 Million0.0% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA2.49MShares$8.13 Million2.68% of portfolio
About Atea Pharmaceuticals, Inc.
- Ticker AVIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,258,600
- Market Cap $272M
- Description
- Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...